Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2.
1. Proteases regulate cells by cleaving proteinase-activated receptors (PARs). Thrombin and trypsin cleave PAR-1 and PAR-2 on neurons and astrocytes of the brain to regulate morphology, growth and survival. We hypothesized that thrombin and mast cell tryptase, which are generated and released during trauma and inflammation, regulate enteric neurons by cleaving PAR-1 and PAR-2. 2. We detected immunoreactive PAR-1 and PAR-2 in > 60 % of neurons from the myenteric plexus of guinea-pig small intestine in primary culture. A large proportion of neurons that expressed substance P, vasoactive intestinal peptide or nitric oxide synthase also expressed PAR-1 and PAR-2. We confirmed expression of PAR-1 and PAR-2 in the myenteric plexus by RT-PCR using primers based on sequences of cloned guinea-pig receptors. 3. Thrombin, trypsin, tryptase, a filtrate from degranulated mast cells, and peptides corresponding to the tethered ligand domains of PAR-1 and PAR-2 increased [Ca2+]i in > 50 % of cultured myenteric neurons. Approximately 60 % of neurons that responded to PAR-1 agonists responded to PAR-2 agonists, and > 90 % of PAR-1 and PAR-2 responsive neurons responded to ATP. 4. These results indicate that a large proportion of myenteric neurons that express excitatory and inhibitory neurotransmitters and purinoceptors also express PAR-1 and PAR-2. Thrombin and tryptase may excite myenteric neurons during trauma and inflammation when prothrombin is activated and mast cells degranulate. This novel action of serine proteases probably contributes to abnormal neurotransmission and motility in the inflamed intestine.
Corvera
C U
CU
Department of Surgery, University of California San Francisco, 521 Parnassus Avenue, San Francisco, CA 94143-0660, USA.
Déry
O
O
McConalogue
K
K
Gamp
P
P
Thoma
M
M
Al-Ani
B
B
Caughey
G H
GH
Hollenberg
M D
MD
Bunnett
N W
NW
D000818:Animals; D000831:Animals, Newborn; D001562:Benzimidazoles / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D053818:Chymases; D003001:Cloning, Molecular; D006168:Guinea Pigs; D006706:Homeostasis; D007150:Immunohistochemistry; D007421:Intestine, Small / Q000294:innervation; D008297:Male; D009197:Myenteric Plexus / Q000502:physiology*; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D009842:Oligopeptides / Q000494:pharmacology; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D018179:Receptors, Thrombin / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D011994:Recombinant Proteins / Q000096:biosynthesis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012697:Serine Endopeptidases / Q000378:metabolism*; D013917:Thrombin / Q000378:metabolism*; D053802:Tryptases; D014660:Vasoactive Intestinal Peptide / Q000032:analysis
D001562:Benzimidazoles; D009842:Oligopeptides; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D018179:Receptors, Thrombin; D011994:Recombinant Proteins; C112356:seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide; D014660:Vasoactive Intestinal Peptide; C025426:bis(5-amidino-2-benzimidazolyl)methane; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D013917:Thrombin; D053802:Tryptases; D002118:Calcium